Benzinga's Top #PreMarket Losers

Regulus Therapeutics Inc.RGLS shares dropped 12.57% to $14.74 in pre-market trading after the company reported top-line results from the 4 mg/kg cohort and additional results from the 2 mg/kg cohort in a completed clinical study evaluating RG-101. Fifth Street Finance Corp. FSC shares declined 8.95% to $7.73 in pre-market trading. Fifth Street Finance reported a Q1 net loss of $30.7 million. Himax Technologies, Inc. HIMX shares fell 5.30% to $7.52 in pre-market trading after dropping 4.45% on Friday. Energy XXI Ltd. EXXI shares dropped 4.72% to $3.63 in pre-market trading after the company reported an adjusted loss of $0.35 per share for the fiscal second quarter. Shire plc SHPG fell 2.32% to $218.46 in pre-market trading after dropping 2.08% on Friday.